All articles by Paladugu Rajesh Kumar

Paladugu Rajesh Kumar

March’s top stories: Baxter to split, first migraine device gets FDA clearance

Baxter revealed its plans to split itself into two separate and independent entities, while Cefaly Technology obtained FDA clearance for its device for preventative treatment of migraine headaches. wraps-up the key headlines from March 2014.

February’s top stories: Thermo Fisher’s $13.6bn deal, Medtronic’s leadless pacemaker

Thermo Fisher Scientific completed its acquisition of Life Technologies, a life sciences company, for approximately $13.6bn, while Medtronic reported the first implant of vitamin-sized leadless pacemaker in US. wraps-up the key headlines from February 2014.

January’s top stories: Carlyle’s $4.15bn acquistion, Edwards Lifesciences’ approval

The Carlyle Group agreed to buy Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business for $4.15bn, while Edwards Lifesciences obtained CE Mark approval for Sapien 3 transcatheter aortic valve. wraps-up the key headlines from January 2014.